跳至主要内容
临床试验/JPRN-UMIN000003447
JPRN-UMIN000003447已完成2 期

Phase II study of chemotherapy with UFT/LV/Bevacizumab in elderly patients with advanced and recurrent colorectal cancer. - Phase II study of chemotherapy with UFT/LV/Bevacizumab in elderly patients with advanced and recurrent colorectal cancer.

Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group0 个研究点目标入组 40 人开始时间: 2010年4月20日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
75years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Medical history of severe anaphylazis or allergia to any drug 2)Active double cancer 3)Serious infection 4)Uncontrolled hypertention 5)Severe complication 6)Massive pleural or abdominal effusion 8)Brain metastasis 9)Severe mental illness 10)Systemic administration of corticosteroids 11)Uric protein 2+ 12)Thrombosis , cerebral infraction , cardiac infraction , pulmonary infraction 13)Patients who underwent surgery within 4 weeks 14)Systemic administration of antiplatelet drug 15)Patients with known bleeding disorders or clotting disorder 16)Patients who are judged inappropriate for the entry into the study by the investigator

研究者

发起方
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group

相似试验